English

AURA BIOSCIENCES, INC.

EDGAR

AURA Quarterly report (10-Q) · filed 2026-08-11

25 filing records in this dataset, filed from 2021-10-08 to 2026-08-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 67.8 million USD 2026-06-30 Source
Exact value

67836000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 103 million shares 2026-06-30 Source
Exact value

103480053 shares

Reported share-count change

66.71% · 41.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

62071050 shares · 2025-06-30· Source
103480053 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-131 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -26130000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -106191000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -80632000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -33685000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -45637000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-103 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -64273000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -44129000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -84700000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -64273000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -29893000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -62394000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -29893000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

344 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 271000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 226000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 447000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 271000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 102000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 123000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 102000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-103 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -64273000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -44129000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -84700000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -64273000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -29893000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -62394000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -29893000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 271000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 226000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 447000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 271000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 102000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 123000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 102000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-11.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 19.27 million

Prior period

−USD 86.92 million

2024-01-01 – 2024-12-31
Current period

−USD 106.19 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-106191000 − -86919000 = -19272000 USD

-86919000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-106191000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Year-over-year change in Net income: -19272000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -106191000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2971763 Filing: 000119312526130401 Input fundies:NetIncome: -86919000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2973711 Filing: 000119312526130401
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 4.9 million

Prior period

−USD 79.81 million

2024-01-01 – 2024-12-31
Current period

−USD 84.7 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-84700000 − -79805000 = -4895000 USD

-79805000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-84700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Year-over-year change in Operating cash flow: -4895000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -84700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2014466 Filing: 000119312526130401 Input fundies:OperatingCashFlow: -79805000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1893660 Filing: 000119312526130401
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-64.3%

Prior period

USD 1.25 million

2024-01-01 – 2024-12-31
Current period

USD 447,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

447000 − 1253000 = -806000 USD

1253000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
447000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Year-over-year change in Capital expenditure: -806000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1898721 Filing: 000119312526130401 Input fundies:CapitalExpenditure: 1253000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1900585 Filing: 000119312526130401
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 22.21 million Exact value Exact value: -22206000 USD 2020-01-01 – 2020-12-31: -22206000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2020-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -22206000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22206000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm#2808105 Filing: 000095017022004425 The citation records this snapshot. The page link may show a newer release later.	−USD 24.32 million Exact value Exact value: -24321000 USD 2020-01-01 – 2020-12-31: -24321000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2020-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -24321000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24321000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm#2013193 Filing: 000095017022004425 The citation records this snapshot. The page link may show a newer release later.	USD 771,000 Exact value Exact value: 771000 USD 2020-01-01 – 2020-12-31: 771000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2020-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 771000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 771000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm#2020377 Filing: 000095017022004425 The citation records this snapshot. The page link may show a newer release later.	−USD 25.09 million Calculation and evidence -24321000 − 771000 USD Exact free cash flow: -25092000 USD 2020-01-01 – 2020-12-31: -24321000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 771000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2020-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -25092000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24321000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm#2013193 Filing: 000095017022004425 Input fundies:CapitalExpenditure: 771000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm#2020377 Filing: 000095017022004425 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 35.25 million Exact value Exact value: -35251000 USD 2021-01-01 – 2021-12-31: -35251000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2021-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -35251000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35251000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm#3075807 Filing: 000095017023008166 The citation records this snapshot. The page link may show a newer release later.	−USD 32.41 million Exact value Exact value: -32410000 USD 2021-01-01 – 2021-12-31: -32410000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2021-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -32410000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32410000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm#2170920 Filing: 000095017023008166 The citation records this snapshot. The page link may show a newer release later.	USD 2.13 million Exact value Exact value: 2125000 USD 2021-01-01 – 2021-12-31: 2125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2021-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 2125000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2125000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm#2178737 Filing: 000095017023008166 The citation records this snapshot. The page link may show a newer release later.	−USD 34.54 million Calculation and evidence -32410000 − 2125000 USD Exact free cash flow: -34535000 USD 2021-01-01 – 2021-12-31: -32410000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2021-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -34535000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32410000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm#2170920 Filing: 000095017023008166 Input fundies:CapitalExpenditure: 2125000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm#2178737 Filing: 000095017023008166 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 58.76 million Exact value Exact value: -58763000 USD 2022-01-01 – 2022-12-31: -58763000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2022-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -58763000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58763000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm#2743526 Filing: 000095017024036814 The citation records this snapshot. The page link may show a newer release later.	−USD 54.6 million Exact value Exact value: -54601000 USD 2022-01-01 – 2022-12-31: -54601000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2022-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -54601000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54601000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm#2088122 Filing: 000095017024036814 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 million Exact value Exact value: 1094000 USD 2022-01-01 – 2022-12-31: 1094000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2022-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 1094000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1094000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm#2093251 Filing: 000095017024036814 The citation records this snapshot. The page link may show a newer release later.	−USD 55.7 million Calculation and evidence -54601000 − 1094000 USD Exact free cash flow: -55695000 USD 2022-01-01 – 2022-12-31: -54601000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1094000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2022-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -55695000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -54601000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm#2088122 Filing: 000095017024036814 Input fundies:CapitalExpenditure: 1094000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm#2093251 Filing: 000095017024036814 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 76.41 million Exact value Exact value: -76408000 USD 2023-01-01 – 2023-12-31: -76408000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2023-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -76408000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -76408000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm#2798327 Filing: 000095017025043943 The citation records this snapshot. The page link may show a newer release later.	−USD 63.85 million Exact value Exact value: -63847000 USD 2023-01-01 – 2023-12-31: -63847000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2023-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -63847000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -63847000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm#1818423 Filing: 000095017025043943 The citation records this snapshot. The page link may show a newer release later.	USD 709,000 Exact value Exact value: 709000 USD 2023-01-01 – 2023-12-31: 709000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2023-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 709000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 709000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm#1824898 Filing: 000095017025043943 The citation records this snapshot. The page link may show a newer release later.	−USD 64.56 million Calculation and evidence -63847000 − 709000 USD Exact free cash flow: -64556000 USD 2023-01-01 – 2023-12-31: -63847000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 709000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2023-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -64556000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -63847000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm#1818423 Filing: 000095017025043943 Input fundies:CapitalExpenditure: 709000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm#1824898 Filing: 000095017025043943 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 86.92 million Exact value Exact value: -86919000 USD 2024-01-01 – 2024-12-31: -86919000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2024-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -86919000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -86919000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2973711 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	−USD 79.81 million Exact value Exact value: -79805000 USD 2024-01-01 – 2024-12-31: -79805000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2024-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -79805000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -79805000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1893660 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	USD 1.25 million Exact value Exact value: 1253000 USD 2024-01-01 – 2024-12-31: 1253000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2024-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 1253000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1253000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1900585 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	−USD 81.06 million Calculation and evidence -79805000 − 1253000 USD Exact free cash flow: -81058000 USD 2024-01-01 – 2024-12-31: -79805000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1253000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2024-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -81058000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -79805000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1893660 Filing: 000119312526130401 Input fundies:CapitalExpenditure: 1253000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1900585 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 106.19 million Exact value Exact value: -106191000 USD 2025-01-01 – 2025-12-31: -106191000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Net Income: -106191000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -106191000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2971763 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	−USD 84.7 million Exact value Exact value: -84700000 USD 2025-01-01 – 2025-12-31: -84700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Operating Cash Flow: -84700000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -84700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2014466 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	USD 447,000 Exact value Exact value: 447000 USD 2025-01-01 – 2025-12-31: 447000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Capital Expenditure: 447000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1898721 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.	−USD 85.15 million Calculation and evidence -84700000 − 447000 USD Exact free cash flow: -85147000 USD 2025-01-01 – 2025-12-31: -84700000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 447000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURA BIOSCIENCES, INC. · 2025-12-31 AURA BIOSCIENCES, INC. (edgar:1501796) Free cash flow: -85147000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1501796?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -84700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#2014466 Filing: 000119312526130401 Input fundies:CapitalExpenditure: 447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm#1898721 Filing: 000119312526130401 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 1,237 latest values · 1,237 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001501796, 1501796, AURA, edgar:1501796

Also known as AURA BIOSCIENCES, INC., Aura Biosciences, Inc.

AURA BIOSCIENCES, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation